T1	condition 66 85	wound complications
T4	total-participants 338 344	Ninety
T5	eligibility 345 396	patients undergoing mastectomy for breast carcinoma
T6	control 446 464	routine wound care
T8	outcome 834 864	rate of ischaemia and necrosis
T9	iv-cont-median 967 971	6·80
T10	cv-cont-median 979 984	23·38
T11	iv-cont-median 1001 1005	3·76
T12	cv-cont-median 1013 1018	23·38
T14	iv-cont-median 1203 1207	1·82
T15	iv-cont-median 1215 1219	6·92
T16	outcome 1250 1274	volume of wound drainage
T17	outcome 1329 1357	incidence of adverse effects
T18	outcome 1452 1465	complications
T19	intervention 29 55	Chinese herbal medications
T20	outcome 948 966	median wound score
T13	outcome 1136 1148	wound scores
T21	outcome 1094 1113	postoperative day 8
T2	intervention 243 278	anisodamine and Salvia miltiorrhiza
